Cargando…
Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis
Unfavorable clinical outcomes mean that cancer researchers must attempt to develop novel therapeutic strategies to overcome therapeutic resistance in patients with HNSCC. Recently, ferroptosis was shown to be a promising pathway possessing druggable targets, such as xCT (SLC7A11). Unfortunately, lit...
Autores principales: | Savic, Dragana, Steinbichler, Teresa Bernadette, Ingruber, Julia, Negro, Giulia, Aschenbrenner, Bertram, Riechelmann, Herbert, Ganswindt, Ute, Skvortsov, Sergej, Dudás, József, Skvortsova, Ira-Ida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856753/ https://www.ncbi.nlm.nih.gov/pubmed/36672272 http://dx.doi.org/10.3390/cells12020336 |
Ejemplares similares
-
Therapy resistance mediated by exosomes
por: Steinbichler, Teresa Bernadette, et al.
Publicado: (2019) -
Epithelial-mesenchymal crosstalk induces radioresistance in HNSCC cells
por: Steinbichler, Teresa Bernadette, et al.
Publicado: (2017) -
Simvastatin Is Effective in Killing the Radioresistant Breast Carcinoma Cells
por: Aschenbrenner, Bertram, et al.
Publicado: (2021) -
KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma
por: Ingruber, Julia, et al.
Publicado: (2021) -
Correction: Epithelial-mesenchymal crosstalk induces radioresistance in HNSCC cells
por: Steinbichler, Teresa Bernadette, et al.
Publicado: (2019)